As you begin the journey of deciding how you will pursue your family building goals following diagnosis of cancer, it is important to know that options are available to you through breakthroughs in medical science. It is likely your oncology specialist has suggested treatment with you which may include chemotherapy, radiation and surgery, and typically the treatment itself may have significant adverse effects on your future fertility. It is recommended, therefore, that whenever possible, you begin considering your reproductive options prior to receiving any treatment. Practical first steps include consulting with a reproductive endocrinologist who will work closely with you and your oncological team. Fertility preservation treatments are available that can safeguard your future fertility and help you achieve your dreams of creating a family. Couples experiencing this difficult time together should know that procedures such as oocyte and embryo cryopreservation (egg and embryo freezing) are available to women just as sperm cryopreservation is available to men. Your fertility preservation treatment can be achieved within weeks and can be scheduled around cancer diagnostic procedures and treatments with your oncology specialist.
At the Mount Sinai-RMA Oncofertility Center, the team of fertility preservation specialists works closely with your treating oncology specialist to ensure integrated, seamless coordination and supervision of your treatment. All staff members of the Oncofertility Center are highly trained in timely organization and handling of tissue to ensure maximum quality cell preservation is underway. The center meticulously abides by all guidelines set forth by state and federal regulations to ensure your cell tissues are carefully protected and stored for future use.
With individualized, compassionate care always a priority, the Mount Sinai-RMA Oncofertility Center’s experienced clinical team will review your options and expectations with you to provide a thorough understanding of the treatments available through the facility and its support network.
The center’s team of highly-respected, board-certified physicians and embryologists are uniquely qualified to offer you the latest treatments in fertility preservation that can offer hope and provide the ability to safeguard your future fertility.
The Mount Sinai-RMA Oncofertility Center is committed to providing you optimal clinical care and places your individual needs at the highest priority. Through years of experience, we are able to provide logistical assistance to your oncology specialist, and will create a customized, comprehensive fertility preservation program for you with no waiting period for consultations or treatment. As our priority patient, you can expect an appointment with one of our physicians within 48 hours. From the moment you contact the center, you will be guided through the process by an experienced fertility preservation coordinator who will assist you in managing individualized treatment as well as ensure that the experience is as stress-free as possible so that you can focus on moving forward with cancer treatment.
The Mount Sinai-RMA Oncofertility Center’s expert finance team will guide you through the financial aspects of fertility preservation. Upon scheduling an appointment, you will receive a dedicated financial coordinator to assist you with insurance and payment matters. In addition, through partnership with the non-profit organization LIVESTRONG, the center is able to offer reduced cost fertility preservation treatments. Our goal is to provide you as many supplementary resources as possible to reduce the financial burden during this stressful time in your life.
The fertility preservation options available to you are determined by age, type and stage of cancer, and the recommended treatment. The necessary course of action requires critical decision-making and communication between you, your oncology specialist and your fertility specialist, and the Mount Sinai-RMA Oncofertility Center team, whose approach has been designed to ensure the safest and most effective outcomes for you as our patient.
The multi-disciplinary team at the Mount Sinai-RMA Oncofertility Center is built on a foundation of hope and is designed to meet the needs of men and women like you who are diagnosed with cancer, and aspire to secure their opportunity to build a family post cancer treatment. Through unparalleled quality patient care and demonstrated excellence in advanced medical technologies, the team is committed to changing lives today and for creating the opportunity for parenthood in years to come.
After cancer treatment, human reproduction can be compromised. RMA of New York is able to provide a variety of procedures for after cancer treatment, when fertility concerns regarding early menopause may arise. Eggs can be frozen without fertilization, or fertilized in the lab to create embryos and then frozen. Both options can provide women with the comfort and confidence of knowing that even after cancer treatment, they can preserve their ability to have their own biological children in the future.
The Livestrong Foundation is a non-profit organization that is dedicated to supporting those whose lives have been impacted by cancer. In support of their mission and in the belief that families facing cancer should not have their reproductive options taken away from them, Reproductive Medicine Associates of New York is proud to partner with Livestrong Fertility in offering discounted post treatment fertility services. These services include egg freezing, embryo freezing and fresh in vitro fertilization cycles to women at risk of becoming infertile. For more information about Livestrong Fertility, you may visit their website at http://www.livestrong.org/we-can-help/fertility or call the RMA of New York office directly at (212) 756-5777.
Single vs. Multiple Embryo Transfer By: Matthew A. Lederman, MD In vitro fertilization (IVF) has evolved dramatically over the last few decades, with more than six million babies now born through assisted reproductive technology. For years, multiple embryos were transferred to the uterus in hopes ...READ MORE
to receive all the latest News, Events & MORE!